Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 655

    1.

    Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.

    Linkins LA, Choi PT, Douketis JD.

    Ann Intern Med. 2003 Dec 2;139(11):893-900.PMID: 14644891 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials.

    Dentali F, Douketis JD, Lim W, Crowther M.

    Arch Intern Med. 2007 Jan 22;167(2):117-24. Review.PMID: 17242311 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.

    Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P.

    Ann Intern Med. 2007 Dec 4;147(11):766-74.PMID: 18056660 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    [Duration of oral anticoagulant therapy in venous thromboembolism]

    Pinède L.

    Rev Med Interne. 2001 Dec;22(12):1225-36. Review. French. PMID: 11794893 [PubMed - indexed for MEDLINE]Related articles

    5.

    Oral anticoagulation for prolonging survival in patients with cancer.

    Akl EA, Kamath G, Kim SY, Yosuico V, Barba M, Terrenato I, Sperati F, Schünemann HJ.

    Cochrane Database Syst Rev. 2007 Apr 18;(2):CD006466. Review.PMID: 17443622 [PubMed - indexed for MEDLINE]Related articles

    6.

    Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

    Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S.

    Lancet. 1996 Aug 17;348(9025):423-8.PMID: 8709780 [PubMed - indexed for MEDLINE]Related articles

    7.

    A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

    Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA.

    N Engl J Med. 1999 Mar 25;340(12):901-7. Erratum in: N Engl J Med 1999 Jul 22;341(4):298. PMID: 10089183 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.

    Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W; Warfarin Optimal Duration Italian Trial Investigators.

    N Engl J Med. 2001 Jul 19;345(3):165-9.PMID: 11463010 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Risk of fatal pulmonary embolism in patients with treated venous thromboembolism.

    Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS.

    JAMA. 1998 Feb 11;279(6):458-62.PMID: 9466640 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Extended oral anticoagulant therapy after a first episode of pulmonary embolism.

    Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M, Imberti D, Poggio R, Ageno W, Pogliani E, Porro F, Zonzin P; Warfarin Optimal Duration Italian Trial Investigators.

    Ann Intern Med. 2003 Jul 1;139(1):19-25.PMID: 12834314 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Duration of anticoagulation following venous thromboembolism: a meta-analysis.

    Ost D, Tepper J, Mihara H, Lander O, Heinzer R, Fein A.

    JAMA. 2005 Aug 10;294(6):706-15.PMID: 16091573 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.

    Ruiz-Irastorza G, Khamashta MA, Hunt BJ, Escudero A, Cuadrado MJ, Hughes GR.

    Arch Intern Med. 2002 May 27;162(10):1164-9.PMID: 12020188 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Duration of anticoagulation therapy for venous thromboembolism.

    Bounameaux H, Perrier A.

    Hematology Am Soc Hematol Educ Program. 2008:252-8.PMID: 19074092 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.
    15.

    Duration of anticoagulant therapy after initial idiopathic venous thromboembolism.

    Frazee LA, Chomo DL.

    Ann Pharmacother. 2003 Oct;37(10):1489-96. Review.PMID: 14519045 [PubMed - indexed for MEDLINE]Related articles

    16.

    Duration of therapy for acute venous thromboembolism.

    Kearon C.

    Clin Chest Med. 2003 Mar;24(1):63-72. Review.PMID: 12685057 [PubMed - indexed for MEDLINE]Related articles

    17.

    Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients.

    Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA.

    Ann Intern Med. 2007 Feb 20;146(4):278-88.PMID: 17310052 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Anticoagulation period in idiopathic venous thromboembolism. How long is enough?

    Farraj RS.

    Saudi Med J. 2004 Jul;25(7):848-51.PMID: 15235686 [PubMed - indexed for MEDLINE]Related articles

    19.

    The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.

    Wells PS, Forgie MA, Simms M, Greene A, Touchie D, Lewis G, Anderson J, Rodger MA.

    Arch Intern Med. 2003 Apr 28;163(8):917-20.PMID: 12719200 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.

    Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M; Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators.

    N Engl J Med. 2003 Aug 14;349(7):631-9.PMID: 12917299 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data